CPC Subgroup Additional Only
C12N 2710/10311 Mastadenovirus, e.g. human or simian adenoviruses
Full Title
dsDNA viruses > Details > Adenoviridae > Mastadenovirus, e.g. human or simian adenoviruses
12 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12N 2710/10321 Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2710/10322 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2710/10323 Virus like particles [VLP]
- C12N 2710/10331 Uses of virus other than therapeutic or vaccine, e.g. disinfectant
- C12N 2710/10332 Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C12N 2710/10333 Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
- C12N 2710/10334 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C12N 2710/10341 Use of virus, viral particle or viral elements as a vector
- C12N 2710/10351 Methods of production or purification of viral material
- C12N 2710/10361 Methods of inactivation or attenuation
- C12N 2710/10371 Demonstrated in vivo effect
- C12N 2710/10388 for redistribution
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692